Skip to main content
. 2020 Feb;8(4):90. doi: 10.21037/atm.2019.12.118

Figure 2.

Figure 2

Survival curve by involved lymph node location in all patients. (A) Survival curve of all patients with positive SCLNs and negative SCLNs, median survival time was 21.0±1.5 and 39.0±2.8 months, respectively; (B) survival curve of patients with SCLNs metastasis and other lymph node metastasis (except for SCLNs), median survival time was 21.0±1.5 and 30.0±3.3 months, respectively. SCLN, supraclavicular lymph node.